Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The Detection of Monkeypox in Humans in the Western Hemisphere
2004740 citationsKurt D. Reed, John W. Melski et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Mark V. Wegner
Since
Specialization
Citations
This map shows the geographic impact of Mark V. Wegner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Wegner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Wegner more than expected).
This network shows the impact of papers produced by Mark V. Wegner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Wegner. The network helps show where Mark V. Wegner may publish in the future.
Co-authorship network of co-authors of Mark V. Wegner
This figure shows the co-authorship network connecting the top 25 collaborators of Mark V. Wegner.
A scholar is included among the top collaborators of Mark V. Wegner based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mark V. Wegner. Mark V. Wegner is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Remington, Patrick, Ross C. Brownson, D A Savitz, & Mark V. Wegner. (2010). Methods in chronic disease epidemiology.. 27–57.1 indexed citations
6.
Remington, Patrick, et al.. (2009). Peer Reviewed: Wisconsin’s Health Department-University Partnership Model for Comprehensive Cancer Control. Preventing Chronic Disease. 6(2).1 indexed citations
7.
Wegner, Mark V., et al.. (2009). Wisconsin's health department-university partnership model for comprehensive cancer control.. PubMed. 6(2). A58–A58.5 indexed citations
Vila, Peter M., Bridget C. Booske, Mark V. Wegner, & Patrick Remington. (2007). Preventable causes of death in Wisconsin, 2004.. PubMed. 106(7). 373–9.1 indexed citations
11.
McElroy, Jane A., et al.. (2006). Updating progress in cancer control in Wisconsin.. PubMed. 105(4). 38–43.3 indexed citations
12.
Vila, Peter M., et al.. (2006). Disparities in oral and pharyngeal cancer incidence and mortality among Wisconsin residents, 1999-2002.. PubMed. 105(6). 32–5.17 indexed citations
13.
Sotir, Mark J., Donita R. Croft, James J. Kazmierczak, et al.. (2005). Meningococcal disease incidence and mortality in Wisconsin, 1993-2002.. PubMed. 104(3). 38–44.2 indexed citations
Reed, Kurt D., John W. Melski, Mary Beth Graham, et al.. (2004). The Detection of Monkeypox in Humans in the Western Hemisphere. New England Journal of Medicine. 350(4). 342–350.740 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.